<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04908293</url>
  </required_header>
  <id_info>
    <org_study_id>2021-WHITESPOTS</org_study_id>
    <nct_id>NCT04908293</nct_id>
  </id_info>
  <brief_title>Home Remineralization of White Spot Lesions With Two Different Toothpastes.</brief_title>
  <official_title>A Comparison Between a Toothpaste With Micro Crystals of Hydroxyapatite and a Toothpaste With 1450 Ppm of Fluoride in the Home Remineralization of White Spot Lesions: a Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare white spot lesions before, during and after treatment with&#xD;
      New Biorepair Advanced Sensitive toothpaste containing micro crystals of hydroxyapatite and&#xD;
      Colgate toothpaste with 1450 ppm of fluoride. The timeline will consider the study begin, 15&#xD;
      days, 30 days and 90 days after the beginning of the study. The following indices will be&#xD;
      recorded: BEWE Index, Schiff Air Index, VAS scale. After that, patients will fill in a&#xD;
      satisfaction questionnaire.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to compare white spot lesions before, during and after treatment with&#xD;
      two different toothpastes for home oral care. Patients who agree to sign the informed consent&#xD;
      will be randomly assigned to two different groups:&#xD;
&#xD;
        -  Trial Group will use New Biorepair Advanced Sensitive toothpaste containing micro&#xD;
           crystals of hydroxyapatite;&#xD;
&#xD;
        -  Control Group will use Colgate toothpaste with 1450 ppm of fluoride.&#xD;
&#xD;
      At the baseline, professional oral hygiene will be performed. The following indices will be&#xD;
      recorded at the study begin and at the following 15, 30 and 90 days: BEWE Index, Schiff Air&#xD;
      Index, VAS scale. After that, patients will fill in a satisfaction questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 28, 2021</start_date>
  <completion_date type="Actual">October 20, 2021</completion_date>
  <primary_completion_date type="Actual">October 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the BEWE Index - Basic Erosive Wear Examination (Barlet et al., 2008)</measure>
    <time_frame>Study begin, 15, 30 and 90 days.</time_frame>
    <description>Scoring criteria:&#xD;
0: no erosive tooth wear;&#xD;
initial loss of surface texture;&#xD;
distinct defect, hard tissue loss &lt; 50% of the surface area;&#xD;
hard tissue loss â‰¥ 50% of the surface area.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Schiff Air Index - Dental sensitivity test</measure>
    <time_frame>Study begin, 15, 30 and 90 days.</time_frame>
    <description>Scoring criteria:&#xD;
0: the subject did not respond to air blasting;&#xD;
the subject responded to air blasting;&#xD;
the subject responded to air blasting and requested discontinuation;&#xD;
the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in VAS score</measure>
    <time_frame>Study begin, 15, 30 and 90 days.</time_frame>
    <description>Evaluation of the evoked pain with air blasting from 0 to 10. The VAS scale is a straight line with the endpoints defining extreme limits with &quot;no pain at all&quot;and &quot;pain as bad as it could be&quot;; they correspond respectively to 0 and 10. The patient indicates the score of the perceived pain from 0 to 10.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>White Spot Lesion</condition>
  <arm_group>
    <arm_group_label>Trial Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of New Biorepair Advanced Sensitive toothpaste for home oral care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of Colgate toothpaste for home oral care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biorepair toothpaste</intervention_name>
    <description>Use of New Biorepair Advanced Sensitive for home oral care.</description>
    <arm_group_label>Trial Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Colgate toothpaste</intervention_name>
    <description>Use of Colgate toothpaste for home oral care.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with white spot lesions;&#xD;
&#xD;
          -  patients with dental sensibility;&#xD;
&#xD;
          -  adult patients;&#xD;
&#xD;
          -  patients that sign the informed consent to participate to the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with low compliance or motivation to participate to the study;&#xD;
&#xD;
          -  patients not presenting white spot lesions;&#xD;
&#xD;
          -  patients with absence of dental sensibility;&#xD;
&#xD;
          -  patients pregnant or breastfeeding;&#xD;
&#xD;
          -  underage patients;&#xD;
&#xD;
          -  patients with psychiatric diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Scribante, DDS, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pavia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia</name>
      <address>
        <city>Pavia</city>
        <state>Lombardy</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 23, 2021</study_first_submitted>
  <study_first_submitted_qc>May 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Andrea Scribante</investigator_full_name>
    <investigator_title>Research Resident, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>remineralization</keyword>
  <keyword>hydroxyapatite</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Listerine</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be available upon motivated request to Principal Investigator.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

